- Report
- March 2024
- 195 Pages
Global
From €3228EUR$3,374USD£2,745GBP
€3587EUR$3,749USD£3,050GBP
- Report
- June 2023
- 129 Pages
Global
From €5692EUR$5,950USD£4,840GBP
- Report
- May 2024
- 89 Pages
Global
From €5358EUR$5,600USD£4,555GBP
- Report
- January 2024
- 150 Pages
Global
From €4640EUR$4,850USD£3,945GBP
- Report
- November 2023
- 178 Pages
Global
From €4688EUR$4,900USD£3,986GBP
- Report
- June 2022
- 260 Pages
Global
From €3994EUR$4,175USD£3,396GBP
- Report
- June 2023
- 94 Pages
Global
From €3500EUR$3,919USD£3,080GBP
The Tropical Disease Test market is a subset of the Infectious Disease Testing market, focusing on the diagnosis of diseases that are endemic to tropical and subtropical regions. These diseases are caused by a variety of pathogens, including bacteria, viruses, fungi, and parasites. Tests used to diagnose tropical diseases include serological tests, such as ELISA and PCR, as well as antigen-based tests. These tests are used to detect the presence of specific pathogens in a patient's sample.
The Tropical Disease Test market is driven by the increasing prevalence of tropical diseases, as well as the need for accurate and timely diagnosis. The market is also driven by the development of new technologies, such as molecular diagnostics, which enable more accurate and rapid diagnosis.
Companies in the Tropical Disease Test market include Abbott Laboratories, Bio-Rad Laboratories, Cepheid, DiaSorin, and Hologic. Show Less Read more